Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cat-PAD in cat allergic rhinoconjunctivitis
NCT01620762Phase 3Completed
- Sponsor
- NIOX Group
- Start
- Oct 2012
- Primary completion
- Jun 2016
- Modality
- Peptides
- Countries
- 9
01
Overview
A Phase 3 trial of Cat-PAD in cat allergy, sponsored by NIOX Group. Started Oct 2012; status: completed.
02
Drugs
Cat-PAD
03
Conditions
cat allergy
Beyond the preview
Go deeper on NCT01620762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01620762.